- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Big Green Snowflakes
Hong Kong Pharmaceuticals & Biotech Big Green Snowflakes
Results
114
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
114 companies
TransThera Sciences (Nanjing)
Market Cap: HK$25.0b
TransThera Sciences (Nanjing), Inc., clinical stage biopharmaceutical company, discovers, develops, and commercializes small molecule therapies for oncology, inflammatory, and cardiometabolic diseases.
2617
HK$63.10
7D
16.5%
1Y
n/a
Luye Pharma Group
Market Cap: HK$14.7b
Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.
2186
HK$3.79
7D
5.3%
1Y
24.3%
JW (Cayman) Therapeutics
Market Cap: HK$2.2b
A clinical stage cell therapy company, engages in the research and development, manufacture, and marketing of cellular immunotherapy products in the People’s Republic of China.
2126
HK$5.33
7D
12.9%
1Y
291.9%
AIM Vaccine
Market Cap: HK$6.2b
Engages in the research and development, manufacture, and sale of vaccine products for human use in the People’s Republic of China.
6660
HK$5.02
7D
3.1%
1Y
17.3%
PuraPharm
Market Cap: HK$175.8m
An investment holding company, engages in research, development, production, and sale of concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally.
1498
HK$0.45
7D
-1.1%
1Y
-36.4%
Sunho Biologics
Market Cap: HK$1.2b
A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics that regulate immune microenvironment by modulating the innate and adaptive immune systems.
2898
HK$7.90
7D
-2.1%
1Y
28.5%
Fusen Pharmaceutical
Market Cap: HK$251.4m
An investment holding company, researches and develops, manufactures, and sells pharmaceutical products in the People’s Republic of China.
1652
HK$0.34
7D
0%
1Y
-66.0%
Sirnaomics
Market Cap: HK$1.6b
An RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs.
2257
HK$14.97
7D
62.0%
1Y
355.0%
Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
Market Cap: HK$8.8b
Engages in the research, development, manufacture, and sale of bio-pharmaceutical products in the People's Republic of China.
1349
HK$3.59
7D
0.6%
1Y
100.6%
China Regenerative Medicine International
Market Cap: HK$240.4m
An investment holding company, provides healthcare products and services in Hong Kong and the People’s Republic of China.
8158
HK$0.79
7D
2.6%
1Y
618.2%
ImmuneOnco Biopharmaceuticals (Shanghai)
Market Cap: HK$5.7b
A biotechnology company, engages in the research and development of immuno-oncology therapies in the People’s Republic of China.
1541
HK$13.98
7D
28.3%
1Y
200.6%
Zhaoke Ophthalmology
Market Cap: HK$2.1b
An ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People’s Republic of China, South Korea, Hong Kong, and internationally.
6622
HK$3.88
7D
10.9%
1Y
185.3%
Tianda Pharmaceuticals
Market Cap: HK$344.0m
Engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia.
455
HK$0.16
7D
-7.4%
1Y
-31.9%
HighTide Therapeutics
Market Cap: HK$2.0b
A clinical-stage biopharmaceutical company, focuses on the development of therapies to treat patients with chronic metabolic and liver diseases in Mainland China.
2511
HK$3.54
7D
3.8%
1Y
202.6%
BioDlink International
Market Cap: HK$1.9b
An investment holding company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in Mainland China and internationally.
1875
HK$2.42
7D
10.0%
1Y
21.6%
Qyuns Therapeutics
Market Cap: HK$5.7b
A clinical-stage biotech company, engages in the research and development of biologic therapies for autoimmune and allergic diseases in the People’s Republic of China.
2509
HK$25.30
7D
5.1%
1Y
-2.1%
XtalPi Holdings
Market Cap: HK$46.0b
An investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.
2228
HK$10.68
7D
3.6%
1Y
-29.4%
Sunshine Lake Pharma
Market Cap: HK$26.6b
Engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology.
6887
HK$53.85
7D
3.7%
1Y
52.2%
Guangzhou Innogen Pharmaceutical Group
Market Cap: HK$18.9b
Engages in development of drugs.
2591
HK$41.46
7D
-6.8%
1Y
n/a
Brii Biosciences
Market Cap: HK$1.5b
Focuses on developing therapies for the treatment of infectious and central nervous system diseases in China and the United States.
2137
HK$2.08
7D
11.8%
1Y
118.9%
PegBio
Market Cap: HK$12.3b
A biopharmaceutical company, focuses on the research and development of medicines for chronic diseases in China.
2565
HK$43.90
7D
22.1%
1Y
n/a
TYK Medicines
Market Cap: HK$5.9b
A clinical-stage biopharmaceutical company, research, development and commercialization of pharmaceutical products.
2410
HK$15.48
7D
5.5%
1Y
-45.5%
3D Medicines
Market Cap: HK$1.9b
A biopharmaceutical company, researches, develops, and commercializes oncology products and other drug candidates for the treatment of patients with various cancers in the People’s Republic of China.
1244
HK$7.63
7D
-6.0%
1Y
161.3%
China NT Pharma Group
Market Cap: HK$863.0m
An investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People’s Republic of China.
1011
HK$1.28
7D
58.0%
1Y
422.4%
Kintor Pharmaceutical
Market Cap: HK$1.1b
A clinical-stage novel drug developer, focuses on developing small molecules and biologic drugs for dermatology and oncology in the People’s Republic of China.
9939
HK$2.37
7D
6.8%
1Y
163.3%
Zhejiang Taimei Medical Technology
Market Cap: HK$2.7b
Zhejiang Taimei Medical Technology Co., Ltd.
2576
HK$4.72
7D
-5.8%
1Y
n/a
Jacobio Pharmaceuticals Group
Market Cap: HK$9.0b
An investment holding company, engages in the in-house discovery and development of oncology therapies.
1167
HK$11.41
7D
40.7%
1Y
583.2%
Mabpharm
Market Cap: HK$3.2b
A biopharmaceutical company, engages in research, development, production, and commercialization of drugs and biosimilar for cancers and autoimmune diseases in the People’s Republic of China.
2181
HK$0.78
7D
-2.5%
1Y
122.9%
Mirxes Holding
Market Cap: HK$11.7b
A micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China.
2629
HK$44.38
7D
-1.4%
1Y
n/a
Beijing Biostar Pharmaceuticals
Market Cap: HK$1.9b
A synthetic biology-driven biopharmaceutical company, engages in the research, development, manufacture, and commercialization of oncology products in the People’s Republic of China.
2563
HK$8.96
7D
3.0%
1Y
n/a
CK Life Sciences Int'l. (Holdings)
Market Cap: HK$8.8b
An investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America.
775
HK$0.92
7D
-1.1%
1Y
159.2%
Sihuan Pharmaceutical Holdings Group
Market Cap: HK$15.1b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China.
460
HK$1.65
7D
13.0%
1Y
200.0%
SinoMab BioScience
Market Cap: HK$3.3b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases primarily monoclonal antibody (mAb)-based biologics in Mainland China and Hong Kong.
3681
HK$2.36
7D
-0.4%
1Y
105.2%
Regent Pacific Group
Market Cap: HK$218.9m
An investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific.
575
HK$0.75
7D
-6.3%
1Y
57.9%
CANbridge Pharmaceuticals
Market Cap: HK$1.2b
A biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare diseases and oncology indications worldwide.
1228
HK$2.45
7D
5.6%
1Y
653.8%
Wuhan YZY Biopharma
Market Cap: HK$1.1b
A biotechnology company, develops bispecific antibody-based therapies for the treatment of cancer, cancer-related complications, and age-related ophthalmologic diseases.
2496
HK$5.50
7D
0%
1Y
-12.4%